2024 annual financial data
Lakefront Biotherapeutics 2024 Operating margin
Lakefront Biotherapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -68.33%.
Operating income was -188,338,000 EUR and net income was 74,082,000 EUR.
Operating cash flow was -320,026,000 EUR.
Get free Lakefront Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 275,649,000 EUR
- Operating income
- -188,338,000 EUR
- Net income
- 74,082,000 EUR
- Operating cash flow
- -320,026,000 EUR